Is Reece Limited a buy?

About Latest Posts Stewart Vella Latest posts by Stewart Vella (see all) The behaviour gap: Why many investors don't beat …

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Reece Ltd (ASX: REH) is an importer, wholesaler, distributor, marketer and retailer of bathroom and plumbing products and services. The company also provides irrigation products, civil products, onsite services, and spare parts for heating, air conditioning, and refrigeration products.

The company operates in an industry where there is a steady and growing demand, and over the last 10 years Reece has reported meaningful and consistent growth. Annualised growth in sales has been 6% over this period, growth in earnings has been 7.2%, and growth in book value has been 10%. The company has also increased its operating margin from 12.8% to 14.7%.

Reece has consistently earned returns on its capital and shareholder equity in the high teens, which, if continued, will lead to healthy growth in intrinsic value. And over time, growth in intrinsic value should lead to growth in the share price. Further, the company has very low levels of debt, which puts them in a strong financial position.

The share price currently trades at a PE ratio of 21 based on forecasted earnings in the year to June 2018. Its enterprise multiple (enterprise value divided by EBITDA) is 13.5. So the stock isn't cheap based in these metrics, but growth is important to consider. Extrapolating the annual growth rate in book value (10%) for the next 10 years, and then assuming a growth rate of 3% into perpetuity, shareholders could expect around a 9% return at the current share price. This is around the market average over the last thirty years.

Foolish Takeaway

Reece is a strong company and looks to be fairly valued at this point in time. I'd be willing to buy a dip should the share price falter any time soon.

Motley Fool contributor Stewart Vella has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »